90 related articles for article (PubMed ID: 6094005)
1. Tamoxifen and conjugated estrogens (Premarin) followed by sequenced methotrexate and 5-FU in refractory advanced breast cancer.
Eisenhauer EA; Bowman DM; Pritchard KI; Paterson AH; Ragaz J; Plenderleith I; Geggie PH; Maxwell I
Cancer Treat Rep; 1984 Nov; 68(11):1421-2. PubMed ID: 6094005
[No Abstract] [Full Text] [Related]
2. Cytoxan, epirubicin, methotrexate and 5-fluorouracil with hormonal synchronization (tamoxifen/premarin) in advanced breast cancer. Preliminary results.
Zaniboni A; Simoncini E; Marpicati P; Gorni F; Cervi GC; Marini G
Chemioterapia; 1986 Oct; 5(5):341-6. PubMed ID: 3024851
[TBL] [Abstract][Full Text] [Related]
3. A randomized attempt to increase the efficacy of cytotoxic chemotherapy in metastatic breast cancer by hormonal synchronization.
Lippman ME; Cassidy J; Wesley M; Young RC
J Clin Oncol; 1984 Jan; 2(1):28-36. PubMed ID: 6321686
[TBL] [Abstract][Full Text] [Related]
4. [Complete regression of breast cancer and its lung metastases after chemohormonotherapy].
Borisov VI; Vorob'ev AN; Stsetsevich NV; Ass NIa
Sov Med; 1986; (12):123-4. PubMed ID: 3563699
[No Abstract] [Full Text] [Related]
5. Treatment of advanced breast cancer: How much chemotherapy is enough?
DiPaola RS; Kaufman A; Mikhail MM
Semin Oncol; 1996 Jun; 23(3):xv-xxii; discussion xxii-xxiv. PubMed ID: 8658211
[No Abstract] [Full Text] [Related]
6. Methotrexate and 5-fluorouracil following tamoxifen and premarin in advanced breast cancer.
Allegra JC
Semin Oncol; 1983 Jun; 10(2 Suppl 2):23-8. PubMed ID: 6306835
[TBL] [Abstract][Full Text] [Related]
7. The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery.
Sorace RA; Bagley CS; Lichter AS; Danforth DN; Wesley MW; Young RC; Lippman ME
World J Surg; 1985 Oct; 9(5):775-85. PubMed ID: 2998103
[No Abstract] [Full Text] [Related]
8. Thymidine kinase and thymidylate synthase in advanced breast cancer: response to tamoxifen and chemotherapy.
Foekens JA; Romain S; Look MP; Martin PM; Klijn JG
Cancer Res; 2001 Feb; 61(4):1421-5. PubMed ID: 11245445
[TBL] [Abstract][Full Text] [Related]
9. Sequential methotrexate and 5-FU in breast cancer resistant to the conventional application of these drugs.
Herrmann R; Manegold C; Schroeder M; Tigges FJ; Bartsch H; Jungi F; Fritze D
Cancer Treat Rep; 1984 Oct; 68(10):1279-81. PubMed ID: 6525599
[TBL] [Abstract][Full Text] [Related]
10. Sequential methotrexate and 5-FU in CMFP (cyclophosphamide, methotrexate, 5-FU, and prednisone) therapy for breast cancer.
Cadman EC; Glick JH; Cross J; Horton J; Taylor SG
Cancer Treat Rep; 1984 Jun; 68(6):877-9. PubMed ID: 6547367
[TBL] [Abstract][Full Text] [Related]
11. Late cardiac effects of adjuvant radiotherapy and chemotherapy in early breast cancer.
Coccaro M; Gallucci G
J Clin Oncol; 2008 Jul; 26(19):3288; author reply 3289. PubMed ID: 18591567
[No Abstract] [Full Text] [Related]
12. [A randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients].
Sack H
Strahlenther Onkol; 1995 Jun; 171(6):360-1. PubMed ID: 7597623
[No Abstract] [Full Text] [Related]
13. Sequential methotrexate plus 5-FU in advanced breast and colorectal cancers: a phase II study.
Kaye SB; Sangster G; Hutcheon A; Habeshaw T; Crossling F; Ferguson C; McArdle C; Smith D; George WD; Calman KC
Cancer Treat Rep; 1984 Mar; 68(3):547-8. PubMed ID: 6704984
[TBL] [Abstract][Full Text] [Related]
14. [Adjuvant endocrine therapy and chemotherapy of breast cancer (author's transl)].
Heuson JC; Paridaens R
Rev Med Brux; 1982 Apr; 3(4):209-16. PubMed ID: 7046007
[No Abstract] [Full Text] [Related]
15. Effect of tamoxifen after chemotherapy in hormone receptor-positive, node-negative breast cancer.
Panasci LC
J Clin Oncol; 2006 May; 24(15):2392; author reply 2392. PubMed ID: 16710042
[No Abstract] [Full Text] [Related]
16. Can biology trump anatomy? Do all node-positive patients with breast cancer need chemotherapy?
Henry NL; Hayes DF
J Clin Oncol; 2007 Jun; 25(18):2501-3. PubMed ID: 17577024
[No Abstract] [Full Text] [Related]
17. [Randomized comparative study of CMF (cyclophosphamide, methotrexate and 5-fluorouracil) and UFT-tamoxifen regimens as adjuvant chemotherapy after surgery for breast cancer: Tochigi Prefectural Study Group for Post-Breast Cancer Adjuvant Chemotherapy].
Tamura H; Kojima M; Kobayashi H; Ando J; Oka S; Fujisaki M; Wada N; Imoto S; Ikeda T
Gan To Kagaku Ryoho; 2000 Jul; 27(7):993-1002. PubMed ID: 10925684
[TBL] [Abstract][Full Text] [Related]
18. [Efficacy of implantable injection port for advanced breast cancer patients].
Nakamura S; Itoh M; Ohigashi S; Nishio T; Abe O; Sakurai K
Gan To Kagaku Ryoho; 1996 Sep; 23(11):1529-32. PubMed ID: 8854798
[TBL] [Abstract][Full Text] [Related]
19. A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer.
Allegra JC; Woodcock TM; Richman SP; Bland KI; Wittliff JL
Breast Cancer Res Treat; 1982; 2(1):93-9. PubMed ID: 6293630
[TBL] [Abstract][Full Text] [Related]
20. Sequential combination chemotherapy in human breast cancer: a basis for increased antineoplastic activity and bone marrow protection.
Davis JH; Desoto JA; Fryar EB; Southerland WM; Bowen D
Cell Mol Biol (Noisy-le-grand); 2007 May; 53(3):18-26. PubMed ID: 17531145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
